RxDoctor Payments Data

Mary Nally, MD

Vascular Surgery · Nashville, TNNPI 1750645750

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $8,608 of the $10,186 with a category attached, or 84.5%. 21 manufacturers reported payments, led by Medtronic at 31.1% of the total. Reporting peaked in 2019 at $3,937 and has fallen 91.2% since, to $346 in 2025.

$10,186in general payments, 2019–2025

Across 123 payments — averaging $82.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Endologix LLC$2K
  • W. L. Gore & Associates, Inc.$1K
  • Silk Road Medical, Inc.$1K
  • Abbott$620
  • Penumbra, Inc.$401
  • plus $2K from 15 others
$6,400in research payments, 2019–2025

Across 1 payment — averaging $6400.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$6K

What the payments were for

  • Travel & lodging$1,57815%
  • Food & beverage$8,60885%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,186 in reported general payments places this provider in the 65th percentile of 117 vascular surgery providers in Tennessee.

See all vascular surgery providers in Tennessee

Medicare billing

Part B allowed, 2024
$165,830
Medicare patients
279
Services billed
897

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate98$1,084
Atorvastatin Calcium58$589
Cilostazol21$222
Rosuvastatin Calcium15$120
Methylprednisolone12$40

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →